![Ultromics receives FDA Clearance for its Breakthrough Device EchoGo Heart Failure: An AI-based platform that enables precision detection of heart failure with preserved ejection fraction Ultromics receives FDA Clearance for its Breakthrough Device EchoGo Heart Failure: An AI-based platform that enables precision detection of heart failure with preserved ejection fraction](https://mma.prnewswire.com/media/1961814/EchoGo_Heart_Failure.jpg?p=facebook)
Ultromics receives FDA Clearance for its Breakthrough Device EchoGo Heart Failure: An AI-based platform that enables precision detection of heart failure with preserved ejection fraction
![Point-of-care screening for heart failure with reduced ejection fraction using artificial intelligence during ECG-enabled stethoscope examination in London, UK: a prospective, observational, multicentre study - The Lancet Digital Health Point-of-care screening for heart failure with reduced ejection fraction using artificial intelligence during ECG-enabled stethoscope examination in London, UK: a prospective, observational, multicentre study - The Lancet Digital Health](https://www.thelancet.com/cms/asset/453f887f-65e1-477e-901e-48284f643c00/gr1.jpg)
Point-of-care screening for heart failure with reduced ejection fraction using artificial intelligence during ECG-enabled stethoscope examination in London, UK: a prospective, observational, multicentre study - The Lancet Digital Health
![Smart wearable devices in cardiovascular care: where we are and how to move forward | Nature Reviews Cardiology Smart wearable devices in cardiovascular care: where we are and how to move forward | Nature Reviews Cardiology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41569-021-00522-7/MediaObjects/41569_2021_522_Fig1_HTML.png)